-
03-12-2018, 09:57 AM
#961
Originally Posted by blackcap
I dont have a subscription so cant see the detail. But any severance should be part of the employment contract and thus no surprise.
-
03-12-2018, 09:59 AM
#962
Originally Posted by minimoke
I dont have a subscription so cant see the detail. But any severance should be part of the employment contract and thus no surprise.
I used my 2 free weekly articles to have a look at this one. The SA is dismayed that Luke is going to get more money after he already has taken $7m while destroying wealth for RBC shareholders. Agree a contract is a contract and if that is the case well its back luck for shareholders.
-
04-12-2018, 05:15 PM
#963
I've noted a some bot trading on this stock over the last couple/few weeks. Low volume stocks not a typical target. Would be interesting to know their agenda. The result seems to be a lower price. Clearly it must be someone trying to win the stock picking contest by way of sabotage...
Last edited by t.rexjr; 04-12-2018 at 07:51 PM.
-
04-12-2018, 10:27 PM
#964
Yes, and it's been for far longer than a few weeks. Very small amounts sold into small bids, then small offers at lower prices than last trade if higher.
Pathetic really, don't they have some shirts to iron or something?
-
06-12-2018, 10:58 AM
#965
Is there some good out there that we should be aware of as there is good interest today with the volume and price ?
Sorry should be RAK !
Last edited by whatsup; 06-12-2018 at 12:04 PM.
Reason: Wrong share
-
06-12-2018, 11:00 AM
#966
Originally Posted by whatsup
Is there some good out there that we should be aware of as there is good interest today with the volume and price ?
Are you sure you are looking at Rubicon. My charts show zero trades so far today.
-
06-12-2018, 11:05 AM
#967
One small buyer at 23c and sellers at 23.5c. All looks normal
-
06-12-2018, 12:16 PM
#968
Member
Last edited by dubya; 06-12-2018 at 07:56 PM.
-
18-12-2018, 09:24 AM
#969
-
18-12-2018, 10:20 AM
#970
Originally Posted by ari
Golly still far to many words.....but the perhaps the key ones are;
"In that respect, the guidance we have provided the market is, that we are targeting a US-GAAP EBITDA1 result for ArborGen for the current scal year to 31 March 2019, approaching US$7 million2,5. As the critical selling season in the US (i.e. Q4 of the scal year) is still to come, at this point we cannot provide much in the way of additional commentary as to how the year-end might play out - other than to say that we believe this earnings target remains achievable,"
Tags for this Thread
Posting Permissions
- You may not post new threads
- You may not post replies
- You may not post attachments
- You may not edit your posts
-
Forum Rules
|
|
Bookmarks